Stryker facing new scrutiny over possible FCPA violations

Michigan-based medical equipment manufacturer Stryker disclosed it is investigating whether certain of its business activities might have violated the Foreign Corrupt Practices Act (FCPA).

Stryker said in a regulatory filing with the Securities and Exchange Commission (SEC) on Tuesday it hired outside counsel to conduct an investigation. The company didn’t name in which country outside the United States the questionable activities might have occurred.

Stryker said it’s been contacted by the SEC and the Department of Justice and is “cooperating with both agencies.”